Cargando…

SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial

• All three vaccines have substantial efficacy in preventing symptomatic and severe Sars-CoV-2 infection. • Vaccine dissemination is important due to the rapid mutagenic nature of the virus and continuing decline in the health and economies around the world. • Further attempts to achieve widespread...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakulavarapu, Srividya, Boneva, Dessy, Elkbuli, Adel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848515/
https://www.ncbi.nlm.nih.gov/pubmed/33552506
http://dx.doi.org/10.1016/j.amsu.2021.01.098
_version_ 1783645154041659392
author Kakulavarapu, Srividya
Boneva, Dessy
Elkbuli, Adel
author_facet Kakulavarapu, Srividya
Boneva, Dessy
Elkbuli, Adel
author_sort Kakulavarapu, Srividya
collection PubMed
description • All three vaccines have substantial efficacy in preventing symptomatic and severe Sars-CoV-2 infection. • Vaccine dissemination is important due to the rapid mutagenic nature of the virus and continuing decline in the health and economies around the world. • Further attempts to achieve widespread access of the vaccine is vital for all preventative measures to be maximally successful.
format Online
Article
Text
id pubmed-7848515
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78485152021-02-01 SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial Kakulavarapu, Srividya Boneva, Dessy Elkbuli, Adel Ann Med Surg (Lond) Editorial • All three vaccines have substantial efficacy in preventing symptomatic and severe Sars-CoV-2 infection. • Vaccine dissemination is important due to the rapid mutagenic nature of the virus and continuing decline in the health and economies around the world. • Further attempts to achieve widespread access of the vaccine is vital for all preventative measures to be maximally successful. Elsevier 2021-02-01 /pmc/articles/PMC7848515/ /pubmed/33552506 http://dx.doi.org/10.1016/j.amsu.2021.01.098 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Kakulavarapu, Srividya
Boneva, Dessy
Elkbuli, Adel
SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial
title SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial
title_full SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial
title_fullStr SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial
title_full_unstemmed SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial
title_short SARS-CoV-2 vaccine candidates: A beginning of the end of COVID-19 pandemic- Editorial
title_sort sars-cov-2 vaccine candidates: a beginning of the end of covid-19 pandemic- editorial
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848515/
https://www.ncbi.nlm.nih.gov/pubmed/33552506
http://dx.doi.org/10.1016/j.amsu.2021.01.098
work_keys_str_mv AT kakulavarapusrividya sarscov2vaccinecandidatesabeginningoftheendofcovid19pandemiceditorial
AT bonevadessy sarscov2vaccinecandidatesabeginningoftheendofcovid19pandemiceditorial
AT elkbuliadel sarscov2vaccinecandidatesabeginningoftheendofcovid19pandemiceditorial